Current Liabilities változás Dátum
Abbott USD 14.35B 180M 2023-06
Accelerate Diagnostics USD 37.79M 15.93M 2023-09
Agilent USD 1.62B 14M 2023-12
Atrion USD 15.27M 1.16M 2023-09
Avanos Medical USD 170.7M 10.2M 2023-09
Becton, Dickinson and Co. USD 7.54B 899M 2023-12
Bruker USD 1.19B 118.7M 2023-12
Catalent USD 1.04B 498M 2023-12
Charles River Laboratories USD 1.06B 61.27M 2023-12
Danaher USD 8.27B 1.09B 2023-12
Exact Sciences USD 514.7M 38.19M 2023-12
Haemonetics USD 261.76M 2.46M 2023-12
Hologic USD 899M 308.3M 2023-12
Illumina USD 1.57B 88M 2023-12
IQVIA Holdings USD 6.49B 98M 2023-12
Merit Medical Systems USD 203.56M 16.43M 2023-12
Mettler Toledo International USD 1.18B 110.66M 2023-12
Myriad Genetics USD 155.9M 53.4M 2023-12
Neogen USD 176.61M 38.48M 2023-09
OraSure Technologies USD 40.95M 5.47M 2023-09
Pacific Biosciences Of California USD 127.97M 143.44M 2023-09
Quidel USD 1.01B 146.6M 2023-12
Revvity USD 1.45B 2.62M 2023-12
Sientra USD 152.09M 63.61M 2023-09
STAAR Surgical USD 65.04M 8.26M 2023-12
Thermo Fisher Scientific USD 14.01B 146M 2023-12
Waters USD 745.03M 64.36M 2023-09



Quidel Rövid Lejáratú Kötelezettségek - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.